Nymox Pharmaceutical (NYMXF) Cash & Current Investments (2015 - 2025)
Nymox Pharmaceutical (NYMXF) recorded Cash & Current Investments of $6,000 in Q4 2025, down 91.9% from $74,000 a year earlier.
Powered by 
Analysis
Nymox Pharmaceutical (NYMXF) Cash & Current Investments (2015 - 2025) Analysis & Trends
Starting with Q4 2015, Nymox Pharmaceutical's Cash & Current Investments history includes 31 quarters.
- Annual Cash & Current Investments has a five-year compound annual growth rate of -72.2% (FY2020 to FY2025).
- Across earlier years, Cash & Current Investments came in at $74,000 in FY2024 (+5.7%), $70,000 in FY2023 (-95.0%), $1.4 million in FY2022 (+69.0%) and $830,000 in FY2021 (-77.0%).
- The Q4 2025 figure is the lowest quarterly Cash & Current Investments in data going back to Q4 2015.
- Peak year-over-year performance for Cash & Current Investments in the last five years was growth of 69.0% in Q4 2022, against a decline of 97.2% in Q3 2023 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 17.23 Bn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | 7.69 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | 11.70 Bn |
| 10 | Nymox Pharmaceutical | 6.12 Mn | 5.93 Mn | - | 6,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 6,000.00 |
| Dec 31, 2024 | 74,000.00 |
| Sep 30, 2024 | 41,000.00 |
| Dec 31, 2023 | 70,000.00 |
| Sep 30, 2023 | 76,000.00 |
| Jun 30, 2023 | 132,000.00 |
| Mar 31, 2023 | 351,000.00 |
| Dec 31, 2022 | 1.40 Mn |
| Sep 30, 2022 | 2.70 Mn |
| Jun 30, 2022 | 4.07 Mn |
| Mar 31, 2022 | 672,000.00 |
| Dec 31, 2021 | 830,000.00 |
| Sep 30, 2021 | 3.14 Mn |
| Dec 31, 2020 | 3.61 Mn |
| Sep 30, 2020 | 5.37 Mn |
| Jun 30, 2020 | 767,000.00 |
| Mar 31, 2020 | 3.00 Mn |
| Dec 31, 2019 | 5.24 Mn |
| Sep 30, 2019 | 7.14 Mn |
| Jun 30, 2019 | 9.10 Mn |
API Access
Nymox Pharmaceutical Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=NYMXF&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "NYMXF", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=NYMXF&period=max&api_key=YOUR_API_KEY");
const data = await res.json();